Felicia Dworkin

New York City Department of Health and Mental Hygiene

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease”.

Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease

Clinical Infectious Diseases(2023)10.1093/cid/ciad312

N/A

0DataRank · unranked

46 citations

Marcos C. Schechter, David Ashkin, Charles A. Peloquin, J. Peter Cegielski, Barbara B Andrino +95 more

Challenges to initiate and complete a 4-month rifapentine-moxifloxacin TB treatment regimen

The International Journal of Tuberculosis and Lung Disease(2025)10.5588/ijtld.24.0616

N/A

0DataRank · unranked

4 citations

Grace Gao, M. M. Salerno, MI Whitehead, Dominique Juste, C. C. Buchanan +7 more